Viewing StudyNCT00289172



Ignite Creation Date: 2024-05-05 @ 4:37 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00289172
Status: COMPLETED
Last Update Posted: 2017-05-30
First Post: 2006-02-08

Brief Title: Assess the Immunogenicity Safety of 2 Doses of Oral Live Attenuated Human RotaHRVVaccine in Healthy Infants in India
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Infections Rotavirus
Keywords: